Extending Applications of Cancer Test

The University of Sunderland and Arquer Diagnostics Ltd, a UK based diagnostics company focused on the development of a diagnostic test for bladder and prostate cancer, are collaborating on investigations into non-invasive specimen preparation techniques, which will facilitate the use of Arquer’s MCM5-ELISA test in a wider range of cancers.

As part of the collaboration, the University will be carrying out in vitro work, using cell lines, to optimise non-invasive sample collection methods which may be compatible with the test. The study is expected to conclude in early 2017.

Commenting on the partnership, Mr Tristan Sillars, Director of Arquer Diagnostics, said: "As we prepare for EU regulatory submission and market launch of our MCM5-ELISA diagnostic test, we are delighted to be working with the University of Sunderland. The partnership has the potential to extend the application of MCM5-ELISA for use in a wider range of cancers, to benefit both patients and clinicians.”